2005, Number 3
<< Back Next >>
Rev Gastroenterol Mex 2005; 70 (3)
Treatment of hepatic encephalopathy with probiotics and prebiotics Cover image:
Bosques-Padilla FJ, Flores-Rendón AR
Language: Spanish
References: 17
Page: 372-374
PDF size: 46.85 Kb.
Text Extraction
No Abstract
REFERENCES
Blei A, Cordoba J. Hepatic encephalopathy. Am J Gastroenterol 2001; 96: 1968-76.
Groenweg M, Quero JC, De Bruijn I, et al. Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 1998; 28: 45-9.
Weissenborn K, Ennen JC, Schomerus H, Ruckery N, Hecker H. Neuropsychological characterization of hepatic encephalopathy. J Hepatol 2001; 34: 768-73.
Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003; 61: 307-13.
Bongaerts GPA, Severijnen RSVM. The beneficial antimicrobial effect of probiotics. Med Hypotheses 2001; 56: 174-7.
Bongaerts GPA, Severijnen RSVM. New strategies in antimicrobial therapy. Med Hypotheses 2001; 56: 178-80.
Vogels GD, Van der Drift C. Degradation of purines and pyrimidines. Bacteriol Rev 1977; 40: 403-68.
Bongaerts GPA, Vogels GD. Uric acid degradation by bacillus fastidiosus strains. J Bacteriol 1976; 125: 689-97.
Cherbut C. Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 2003; 62: 95-9.
Gibson GR. Dietary modulation of the human gut microflora using the prebiotics oligofructose and inulin. J Nutr 1999; 129: 1438s-1441s.
Kandler O, Weiss N. Regular, nonsporing gram-positive rods. Genus Lactobacillus. In: Sneath PHA (ed.). Bergey’s manual of systematic bacteriology. Vol. 2. Baltimore, USA: Williams&Wilkins; 1986, p. 1209-34.
Liu Q, Duan ZP, Ha da K, Bengmark S, Kurtovic J, Riordan SM. Symbiotic modulation of gut flora: effect on minimal hepatic encephalopathy in patients with cirrhosis. Hepatology 2004; 39: 1441-9.
Solga SF, Diehl AM. Gut flora-based therapy in liver disease? The liver cares about the gut. Hepatology 2004; 39: 1197-200.
Vilstrup H. Cirrhosis and bacterial infections. Rom J Gastroenterol 2003; 12: 297-302.
Borriello SP, Hammes WP, Holzapfel W, Marteau P, Schrezenmeir J, Vaara M, Valtonen V. Safety of probiotics that contain lactobacilli or bifidobacteria. Clin Infect Dis 2003; 36: 775-80.
Fontanarosa P, Rennie D, DeAngelis C. The need for regulation of dietary supplements-lessons from ephedra. JAMA 2003; 289: 1568-70.
Joint FAO/WHO Working Group Report on Drafting Guidelines for the Evaluation of Probiotics in Food London, Ontario, Canada, April 30 and May 1, 2002.